4153 Stock Overview
Manufactures and sells display solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
DIVA Laboratories, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$39.15 |
| 52 Week High | NT$55.80 |
| 52 Week Low | NT$34.45 |
| Beta | 0.34 |
| 1 Month Change | -6.56% |
| 3 Month Change | -23.08% |
| 1 Year Change | 5.81% |
| 3 Year Change | 43.14% |
| 5 Year Change | 10.71% |
| Change since IPO | 137.58% |
Recent News & Updates
Shareholder Returns
| 4153 | TW Electronic | TW Market | |
|---|---|---|---|
| 7D | 0.1% | 1.7% | 0.4% |
| 1Y | 5.8% | 27.6% | 28.7% |
Return vs Industry: 4153 underperformed the TW Electronic industry which returned 25.5% over the past year.
Return vs Market: 4153 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 4153 volatility | |
|---|---|
| 4153 Average Weekly Movement | 5.0% |
| Electronic Industry Average Movement | 5.3% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4153 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4153's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Zhiheng Zhao | www.diva.com.tw |
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. The company provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays/human machine interface products; medical and industrial cases; and displays to ODM and OEM customers. It also offers video solutions.
DIVA Laboratories, Ltd. Fundamentals Summary
| 4153 fundamental statistics | |
|---|---|
| Market cap | NT$2.30b |
| Earnings (TTM) | NT$91.51m |
| Revenue (TTM) | NT$843.92m |
25.1x
P/E Ratio2.7x
P/S RatioIs 4153 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4153 income statement (TTM) | |
|---|---|
| Revenue | NT$843.92m |
| Cost of Revenue | NT$602.97m |
| Gross Profit | NT$240.95m |
| Other Expenses | NT$149.44m |
| Earnings | NT$91.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.56 |
| Gross Margin | 28.55% |
| Net Profit Margin | 10.84% |
| Debt/Equity Ratio | 0% |
How did 4153 perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield80%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 13:08 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DIVA Laboratories, Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Hsiu Chi Lin | Masterlink Securities Corp. |